Mutations modifying sporadic Alzheimer's disease age of onset

ABSTRACT: The identification of mutations modifying the age of onset (AOO) in Alzheimer’s disease (AD) is crucial for understanding the natural history of AD and, therefore, for early interventions. Patients with sporadic AD (sAD) from a genetic isolate in the extremes of the AOO distribution were w...

Full description

Autores:
Lopera Restrepo, Francisco Javier
Vélez Valbuena, Jorge Iván
Hardip, Patel
Angad, Johar
Cai, Yeping
Rivera D., Dora
Tobón Quintero, Carlos Andrés
Villegas, Andrés
Sepúlveda Falla, Diego
Lehmann, Shaun
Easteal, Simon
Mastronardi, Claudio
Arcos Burgos, Oscar Mauricio
Tipo de recurso:
Article of investigation
Fecha de publicación:
2016
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/35187
Acceso en línea:
https://hdl.handle.net/10495/35187
Palabra clave:
Enfermedad de Alzheimer
Alzheimer Disease
Fenotipo
Phenotype
Mutación
Mutation
Genotipo
Genotype
Exoma
Exome
Genes Modificadores
Genes, Modifier
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
Description
Summary:ABSTRACT: The identification of mutations modifying the age of onset (AOO) in Alzheimer’s disease (AD) is crucial for understanding the natural history of AD and, therefore, for early interventions. Patients with sporadic AD (sAD) from a genetic isolate in the extremes of the AOO distribution were whole-exome genotyped. Single- and multi-locus linear mixed-effects models were used to identify functional variants modifying AOO. A posteriori enrichment and bioinformatic analyses were applied to evaluate the non-random clustering of the associate variants to physiopathological pathways involved in AD. We identified more than 20 pathogenic, genome-wide statistically significant mutations of major modifier effect on the AOO. These variants are harbored in genes implicated in neuron apoptosis, neurogenesis, inflammatory processes linked to AD, ligodendrocyte differentiation, and memory processes. This set of new genes harboring these mutations could be of importance for prediction, follow-up and eventually as therapeutical targets of AD.